Correction: Alteration of introns in a hyaluronan synthase 1 (HAS1) minigene convert pre-mRNA splicing to the aberrant pattern in multiple myeloma (MM): MM patients harbor similar changes(PLoS ONE 8, 1, (e53469) DOI:10.1371/journal.pone.0053469);Alteration of Introns in a Hyaluronan Synthase 1 (HAS1) Minigene Convert Pre-Mrna Splicing to the Aberrant Pattern in Multiple Myeloma (MM): MM Patients Harbor Similar Changes

PLoS ONE

Volumn 8, Issue 1, 2013, Pages

  Kriangkum, Jitra ^a   Warkinton, Amanda ^a   Belch, Andrew R ^a   Pilarski, Linda M ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; MESSENGER RNA;

ARTICLE; CONTROLLED STUDY; EXON; GENE DELETION; GENE EXPRESSION REGULATION; GENE IDENTIFICATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HYALURONAN SYNTHASE 1 GENE; IN VITRO STUDY; IN VIVO STUDY; INTRON; MULTIPLE MYELOMA; MUTAGENESIS; MUTATIONAL ANALYSIS; MYELOMA CELL; RNA SPLICING; SEQUENCE ANALYSIS; TRANSCRIPTION INITIATION; TUMOR GENE; UPREGULATION;

EID: 84871905869     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/annotation/9984da27-0e7f-4c7f-bcd3-bef1a4c0be87     Document Type: Erratum

References (36)

1. Kalnina Z, Zayakin P, Silina K, Line A, (2005) Alterations of pre-mRNA splicing in cancer. Genes Chromosomes Cancer 42: 342-357.
2. Venables JP, (2004) Aberrant and alternative splicing in cancer. Cancer Res 64: 7647-7654.
3. Venables JP, (2006) Unbalanced alternative splicing and its significance in cancer. Bioessays 28: 378-386.
4. Buratti E, Baralle M, Baralle FE, (2006) Defective splicing, disease and therapy: searching for master checkpoints in exon definition. Nucleic Acids Res 34: 3494-3510.
5. Pagani F, Baralle FE, (2004) Genomic variants in exons and introns: identifying the splicing spoilers. Nat Rev Genet 5: 389-396.
6. Cartegni L, Chew SL, Krainer AR, (2002) Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet 3: 285-298.
7. Colgin LM, Hackmann AF, Monnat RJ Jr, (1999) Different somatic and germline HPRT1 mutations promote use of a common, cryptic intron 1 splice site. Mutation in brief no. 259. Online. Hum Mutat 14: 92.
8. Moon SD, Park JH, Kim EM, Kim JH, Han JH, et al. (2005) A Novel IVS2-1G>A mutation causes aberrant splicing of the HRPT2 gene in a family with hyperparathyroidism-jaw tumor syndrome. J Clin Endocrinol Metab 90: 878-883.
9. Agrawal S, Pilarski R, Eng C, (2005) Different splicing defects lead to differential effects downstream of the lipid and protein phosphatase activities of PTEN. Hum Mol Genet 14: 2459-2468.
10. Auclair J, Busine MP, Navarro C, Ruano E, Montmain G, et al. (2006) Systematic mRNA analysis for the effect of MLH1 and MSH2 missense and silent mutations on aberrant splicing. Hum Mutat 27: 145-154.
11. Lastella P, Surdo NC, Resta N, Guanti G, Stella A, (2006) In silico and in vivo splicing analysis of MLH1 and MSH2 missense mutations shows exon- and tissue-specific effects. BMC Genomics 7: 243.
12. Pagenstecher C, Wehner M, Friedl W, Rahner N, Aretz S, et al. (2006) Aberrant splicing in MLH1 and MSH2 due to exonic and intronic variants. Hum Genet 119: 9-22.
13. Durocher F, Labrie Y, Soucy P, Sinilnikova O, Labuda D, et al. (2006) Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families. BMC Cancer 6: 230.
14. Staalesen V, Falck J, Geisler S, Bartkova J, Borresen-Dale AL, et al. (2004) Alternative splicing and mutation status of CHEK2 in stage III breast cancer. Oncogene 23: 8535-8544.
15. Ludes-Meyers JH, Bednarek AK, Popescu NC, Bedford M, Aldaz CM, (2003) WWOX, the common chromosomal fragile site, FRA16D, cancer gene. Cytogenet Genome Res 100: 101-110.
16. Takahashi T, D'Amico D, Chiba I, Buchhagen DL, Minna JD, (1990) Identification of intronic point mutations as an alternative mechanism for p53 inactivation in lung cancer. J Clin Invest 86: 363-369.
17. Lamolle G, Marin M, Alvarez-Valin F, (2006) Silent mutations in the gene encoding the p53 protein are preferentially located in conserved amino acid positions and splicing enhancers. Mutat Res 600: 102-112.
18. Adamia S, Crainie M, Kriangkum J, Mant MJ, Belch AR, et al. (2003) Abnormal expression of hyaluronan synthases in patients with Waldenstrom's macroglobulimenia. Semin Oncol 30: 165-168.
19. Adamia S, Reiman T, Crainie M, Mant MJ, Belch AR, et al. (2005) Intronic splicing of hyaluronan synthase 1 (HAS1): a biologically relevant indicator of poor outcome in multiple myeloma. Blood 105: 4836-4844.
20. Ghosh A, Kuppusamy H, Pilarski LM, (2009) Aberrant splice variants of HAS1 (Hyaluronan Synthase 1) multimerize with and modulate normally spliced HAS1 protein: a potential mechanism promoting human cancer. J Biol Chem 284: 18840-18850.
21. Adamia S, Reichert AA, Kuppusamy H, Kriangkum J, Ghosh A, et al. (2008) Inherited and acquired variations in the hyaluronan synthase 1 (HAS1) gene may contribute to disease progression in multiple myeloma and Waldenstrom macroglobulinemia. Blood 112: 5111-5121.
22. Horton RM, Cai ZL, Ho SN, Pease LR, (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. Biotechniques 8: 528-535.
23. Adamia S, Pilarski PM, Belch AR, Pilarski LM, (2009) Genetic abnormalities in Waldenstrom's macroglobulinemia. Clin Lymphoma Myeloma 9: 30-32.
24. Luco RF, Allo M, Schor IE, Kornblihtt AR, Misteli T, (2011) Epigenetics in alternative pre-mRNA splicing. Cell 144: 16-26.
25. Black DL, (2003) Mechanisms of alternative pre-messenger RNA splicing. Annu Rev Biochem 72: 291-336.
26. Nussinov R, (1987) (A)GGG(A), (A)CCC(A) and other potential 3′ splice signals in primate nuclear pre-mRNA sequences. Biochim Biophys Acta 910: 261-270.
27. Nussinov R, (1989) Conserved signals around the 5′ splice sites in eukaryotic nuclear precursor mRNAs: G-runs are frequent in the introns and C in the exons near both 5′ and 3′ splice sites. J Biomol Struct Dyn 6: 985-1000.
28. Carlo T, Sterner DA, Berget SM, (1996) An intron splicing enhancer containing a G-rich repeat facilitates inclusion of a vertebrate micro-exon. RNA 2: 342-353.
29. Han K, Yeo G, An P, Burge CB, Grabowski PJ, (2005) A combinatorial code for splicing silencing: UAGG and GGGG motifs. PLoS Biol 3: e158.
30. McCullough AJ, Berget SM, (1997) G triplets located throughout a class of small vertebrate introns enforce intron borders and regulate splice site selection. Mol Cell Biol 17: 4562-4571.
31. Sirand-Pugnet P, Durosay P, Brody E, Marie J, (1995) An intronic (A/U)GGG repeat enhances the splicing of an alternative intron of the chicken beta-tropomyosin pre-mRNA. Nucleic Acids Res 23: 3501-3507.
32. Marcucci R, Baralle FE, Romano M, (2007) Complex splicing control of the human Thrombopoietin gene by intronic G runs. Nucleic Acids Res 35: 132-142.
33. Adamia S, Treon SP, Reiman T, Tournilhac O, McQuarrie C, et al. (2005) Potential impact of a single nucleotide polymorphism in the hyaluronan synthase 1 gene in Waldenstrom's macroglobulinemia. Clin Lymphoma 5: 253-256.
34. Carlo T, Sierra R, Berget SM, (2000) A 5′ splice site-proximal enhancer binds SF1 and activates exon bridging of a microexon. Mol Cell Biol 20: 3988-3995.
35. Wang Z, Rolish ME, Yeo G, Tung V, Mawson M, et al. (2004) Systematic identification and analysis of exonic splicing silencers. Cell 119: 831-845.
36. Bechtel JM, Rajesh P, Ilikchyan I, Deng Y, Mishra PK, et al. (2008) Calculation of splicing potential from the Alternative Splicing Mutation Database. BMC Res Notes 1: 4.